Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 9 | 2025 | 1039 | 2.150 |
Why?
|
| Hypersensitivity | 2 | 2025 | 162 | 1.480 |
Why?
|
| Epigenesis, Genetic | 4 | 2025 | 555 | 0.940 |
Why?
|
| DNA Methylation | 7 | 2025 | 697 | 0.900 |
Why?
|
| Genome-Wide Association Study | 7 | 2023 | 1762 | 0.790 |
Why?
|
| Sex Characteristics | 3 | 2021 | 333 | 0.750 |
Why?
|
| Polymorphism, Single Nucleotide | 11 | 2021 | 2484 | 0.720 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 28 | 0.670 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 46 | 0.660 |
Why?
|
| Genes, X-Linked | 1 | 2021 | 39 | 0.650 |
Why?
|
| Leukocytes | 1 | 2021 | 210 | 0.610 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 134 | 0.610 |
Why?
|
| Linkage Disequilibrium | 5 | 2010 | 478 | 0.590 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2025 | 2465 | 0.570 |
Why?
|
| Puberty | 1 | 2018 | 54 | 0.540 |
Why?
|
| Multigene Family | 2 | 2010 | 203 | 0.520 |
Why?
|
| Estrogens | 1 | 2018 | 195 | 0.520 |
Why?
|
| Genotype | 9 | 2025 | 1866 | 0.510 |
Why?
|
| Cytokines | 1 | 2020 | 863 | 0.480 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 1117 | 0.480 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 317 | 0.460 |
Why?
|
| Gene Frequency | 5 | 2011 | 700 | 0.450 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2006 | 77 | 0.440 |
Why?
|
| Child | 8 | 2025 | 7355 | 0.430 |
Why?
|
| CpG Islands | 2 | 2025 | 168 | 0.400 |
Why?
|
| Chimerism | 1 | 2013 | 38 | 0.380 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 59 | 0.370 |
Why?
|
| Primates | 1 | 2012 | 157 | 0.340 |
Why?
|
| Phenotype | 4 | 2025 | 2544 | 0.320 |
Why?
|
| Olfactory Perception | 1 | 2010 | 23 | 0.310 |
Why?
|
| Quantitative Trait Loci | 4 | 2021 | 630 | 0.300 |
Why?
|
| Receptors, Odorant | 1 | 2010 | 38 | 0.300 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 826 | 0.300 |
Why?
|
| Hominidae | 1 | 2010 | 106 | 0.300 |
Why?
|
| Interleukin-4 | 1 | 2009 | 134 | 0.300 |
Why?
|
| Genetic Variation | 3 | 2005 | 1415 | 0.280 |
Why?
|
| HLA Antigens | 1 | 2010 | 228 | 0.280 |
Why?
|
| Haplotypes | 4 | 2012 | 647 | 0.280 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 36 | 0.260 |
Why?
|
| Integrin beta3 | 1 | 2007 | 31 | 0.260 |
Why?
|
| Immunophenotyping | 1 | 2007 | 224 | 0.250 |
Why?
|
| Genetics, Population | 1 | 2010 | 439 | 0.250 |
Why?
|
| Adolescent | 7 | 2023 | 9606 | 0.240 |
Why?
|
| Infant | 3 | 2025 | 3220 | 0.240 |
Why?
|
| Cohort Studies | 3 | 2025 | 3054 | 0.240 |
Why?
|
| Bayes Theorem | 2 | 2025 | 402 | 0.240 |
Why?
|
| Child, Preschool | 3 | 2025 | 3829 | 0.230 |
Why?
|
| Humans | 22 | 2025 | 93515 | 0.230 |
Why?
|
| Receptors, Steroid | 1 | 2005 | 43 | 0.230 |
Why?
|
| Models, Genetic | 2 | 2012 | 970 | 0.220 |
Why?
|
| Male | 11 | 2025 | 44557 | 0.220 |
Why?
|
| Rhinitis, Allergic | 1 | 2025 | 52 | 0.220 |
Why?
|
| Nasal Mucosa | 1 | 2025 | 193 | 0.220 |
Why?
|
| Water-Electrolyte Balance | 1 | 2004 | 68 | 0.220 |
Why?
|
| Female | 12 | 2025 | 48702 | 0.210 |
Why?
|
| Young Adult | 6 | 2021 | 6930 | 0.210 |
Why?
|
| Evolution, Molecular | 3 | 2012 | 878 | 0.210 |
Why?
|
| Species Specificity | 3 | 2012 | 684 | 0.210 |
Why?
|
| Environment | 1 | 2005 | 230 | 0.200 |
Why?
|
| Lung | 3 | 2023 | 1366 | 0.190 |
Why?
|
| Aging | 1 | 2007 | 727 | 0.180 |
Why?
|
| DNA | 2 | 2023 | 1265 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1985 | 0.170 |
Why?
|
| Base Sequence | 4 | 2011 | 2220 | 0.160 |
Why?
|
| Adult | 8 | 2023 | 27918 | 0.160 |
Why?
|
| Genomics | 2 | 2023 | 848 | 0.160 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2020 | 73 | 0.160 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 7061 | 0.150 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 2910 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 220 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 301 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2010 | 127 | 0.140 |
Why?
|
| Endocrine System | 1 | 2018 | 16 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 109 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 208 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2021 | 463 | 0.130 |
Why?
|
| Middle Aged | 6 | 2021 | 27573 | 0.130 |
Why?
|
| Immunity | 1 | 2018 | 153 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 691 | 0.120 |
Why?
|
| Aged | 4 | 2021 | 20434 | 0.120 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2006 | 41 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1518 | 0.110 |
Why?
|
| Alleles | 2 | 2012 | 1139 | 0.110 |
Why?
|
| Phylogeny | 3 | 2012 | 1266 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 893 | 0.110 |
Why?
|
| DNA Primers | 2 | 2005 | 531 | 0.100 |
Why?
|
| Risk Factors | 2 | 2020 | 5899 | 0.100 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 8 | 0.100 |
Why?
|
| beta-Defensins | 1 | 2013 | 12 | 0.100 |
Why?
|
| Biomarkers | 1 | 2020 | 1910 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.100 |
Why?
|
| Chemokines, CC | 1 | 2013 | 36 | 0.100 |
Why?
|
| South Dakota | 2 | 2010 | 47 | 0.100 |
Why?
|
| Cercopithecidae | 1 | 2012 | 14 | 0.100 |
Why?
|
| Genome, Mitochondrial | 1 | 2012 | 32 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 200 | 0.090 |
Why?
|
| Respiration | 1 | 2013 | 269 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 78 | 0.080 |
Why?
|
| Microvessels | 1 | 2011 | 68 | 0.080 |
Why?
|
| Exons | 1 | 2012 | 450 | 0.080 |
Why?
|
| Blood Group Antigens | 1 | 2010 | 15 | 0.080 |
Why?
|
| Endangered Species | 1 | 2010 | 26 | 0.080 |
Why?
|
| Animals, Wild | 1 | 2010 | 52 | 0.080 |
Why?
|
| Animals | 5 | 2012 | 28155 | 0.080 |
Why?
|
| Pheromones, Human | 1 | 2010 | 7 | 0.080 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 1052 | 0.080 |
Why?
|
| Animals, Zoo | 1 | 2010 | 75 | 0.080 |
Why?
|
| Founder Effect | 1 | 2010 | 106 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2012 | 261 | 0.070 |
Why?
|
| Logistic Models | 1 | 2013 | 1243 | 0.070 |
Why?
|
| Lipoprotein(a) | 1 | 2009 | 28 | 0.070 |
Why?
|
| Introns | 1 | 2009 | 300 | 0.070 |
Why?
|
| Pregnancy | 2 | 2013 | 3147 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 300 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2010 | 613 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 381 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 295 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2007 | 39 | 0.060 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2007 | 64 | 0.060 |
Why?
|
| Geography | 2 | 2004 | 240 | 0.060 |
Why?
|
| Mutation | 2 | 2012 | 4272 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 894 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2005 | 256 | 0.050 |
Why?
|
| Los Angeles | 1 | 2004 | 28 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2004 | 84 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2715 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 209 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2023 | 136 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 1133 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 1105 | 0.050 |
Why?
|
| Duffy Blood-Group System | 1 | 2001 | 8 | 0.040 |
Why?
|
| Binding Sites | 1 | 2004 | 1133 | 0.040 |
Why?
|
| Genes, erbB-2 | 1 | 2021 | 25 | 0.040 |
Why?
|
| Rhinovirus | 1 | 2021 | 29 | 0.040 |
Why?
|
| Algorithms | 1 | 2010 | 1953 | 0.040 |
Why?
|
| Genome, Human | 1 | 2005 | 823 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 2365 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 648 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 700 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 2001 | 538 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1301 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 1691 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 440 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 71 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 155 | 0.020 |
Why?
|
| NADH Dehydrogenase | 1 | 2012 | 22 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2012 | 40 | 0.020 |
Why?
|
| Trophoblasts | 1 | 2012 | 35 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 413 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 884 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 887 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 353 | 0.020 |
Why?
|
| Kringles | 1 | 2009 | 6 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 696 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Religion | 1 | 2009 | 89 | 0.020 |
Why?
|
| Chicago | 1 | 2012 | 1464 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1799 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2464 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 295 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1338 | 0.010 |
Why?
|
| Pakistan | 1 | 2001 | 17 | 0.010 |
Why?
|
| Cameroon | 1 | 2001 | 19 | 0.010 |
Why?
|
| Italy | 1 | 2001 | 110 | 0.010 |
Why?
|
| Population Density | 1 | 2001 | 70 | 0.010 |
Why?
|
| China | 1 | 2001 | 264 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7622 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 419 | 0.010 |
Why?
|